Jul 18, 2016 - Three drug stocks including industry bellwether Johnson & Johnson (JNJ) will report results on Jul 19.
Jul 14, 2016 - Novartis AG (NVS) announced that the FDA's Arthritis Advisory Committee has recommended an approval of the company's proposed biosimilar of Amgen's (AMGN) blockbuster drug, Enbrel (etanercept).
Jul 14, 2016 - Amgen (AMGN) inked an exclusive agreement with Daiichi Sankyo for the commercialization of nine biosimilars in Japan.
Jul 14, 2016 - The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx
Jul 13, 2016 - Immuno-oncology focused Juno (JUNO) remained in the news with the FDA first placing a clinical hold on a pivotal study and then removing it.
Jul 12, 2016 - Amgen's (AMGN) PCSK9 inhibitor Repatha becomes the first and the only one to gain FDA approval for a monthly single-dose administration.
Apr 29, 2016 - Amgen, Inc. (NASDAQ:AMGN)Q1 2016 Earnings CallApril 28, 2016 5:30 pm ETExecutivesArvind K. Sood - Vice President-Investor RelationsRobert A. Bradway - Chairman, President & Chief Executive OfficerDavi
Apr 28, 2016 - Earnings Conference Call Start time: April 28, 2016 at 17:30 PM ET.The audio will stream live while the call is active and can be replayed upon its completion.
Sep 23, 2015 - Hillary Clinton's tweet about skyrocketing drug prices triggered a sell-off in the biotech sector reflecting concerns regarding the implementation of price control measures.
Sep 23, 2015 - Selloff in commodity, auto and biotech stocks dragged benchmarks lower on Tuesday